Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
Cell & Bioscience|June 23, 2026
Cellular prion protein and its derived peptides: multifaceted roles in neurodegenerative diseases and potential as biomarkersEmanuela Mari, Michele Aventaggiato, Emanuela Paldino, et al.Brain : a Journal of Neurology|July 11, 2024
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body diseaseLorenzo Barba, Samir Abu-Rumeileh, Henryk Barthel, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 9, 2022
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's diseaseLorenzo Barba, Samir Abu Rumeileh, Giovanni Bellomo, et al.Neurology|May 15, 2023
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body DiseaseLorenzo Barba, Samir Abu-Rumeileh, Steffen Halbgebauer, et al.Journal of the Neurological Sciences|June 8, 2024
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseasesLorenzo Barba, Giovanni Bellomo, Patrick Oeckl, et al.Chembiochem : a European Journal of Chemical Biology|January 18, 2023
Modulation of Aβ42 Aggregation Kinetics and Pathway by Low-Molecular-Weight InhibitorsMarie-Theres Hutchison, Giovanni Bellomo, Alexey Cherepanov, et al.Frontiers in Neuroscience|April 19, 2021
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological DisordersGiovanni Bellomo, Antonio Indaco, Davide Chiasserini, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2024
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assayGiovanni Bellomo, Andrea Toja, Federico Paolini Paoletti, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 26, 2025
Serum level changes of the synaptic marker beta-synuclein in Alzheimer's disease continuum and other dementiasLorenzo Barba, Giovanni Bellomo, Daniel Alcolea, et al.Alzheimer'S Research & Therapy|July 15, 2023
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuumSilvia Paciotti, Anna Lidia Wojdała, Giovanni Bellomo, et al.Pageof 6